Spatial Proteomic Analysis of Antimicrobial Therapeutic-Releasing Intracortical Probes
The study uses spatial proteomics to assess tissue around non-functional intracortical microelectrodes implanted for four weeks in mice, measuring neuronal integrity, immune-cell activation and local cytokine expression around probes coated with drug-loaded, controlled-release titanium dioxide nanotube array (TNA) coatings. The authors note that blood-brain barrier disruption can translocate gut-derived bacteria to the implant site and sustain chronic inflammation, and that the TNA coating's therapeutic loading and controlled release further damp residual neuroinflammation. They conclude that TNA offers a multifunctional, tunable interface for locally regulating the neuroimmune microenvironment, a step toward long-term reliable intracortical recordings.
Why it matters
Spatial proteomics turns the neuroimmune response — the factor that has long capped intracortical recording stability — into a measurable, tunable coating variable, supplying platform data for future recording- and stimulation-probe design.